Cardiac safety of laquinimod in healthy subjects

Trial Profile

Cardiac safety of laquinimod in healthy subjects

Phase of Trial: Phase I

Latest Information Update: 18 Feb 2016

At a glance

  • Drugs Laquinimod (Primary) ; Moxifloxacin
  • Indications Crohn's disease; Huntington's disease; Multiple sclerosis
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top